Breaking News, Financial News

4Q Financial Reports: Abbott

Abbott

4Q Revenues: $6 billion (+7%)

4Q Earnings: $976 million (flat)

FY Revenues: $22.3 billion (+13.5%)

FY Earnings: $3.4 billion (+4%)

Comments: Abbott achieved records sales for the quarter and the year. Pharmaceutical Products Group sales grew 10% in the quarter, driven by performance of Humira and contributions from TriCor and Omnicef. Worldwide sales of Humira were $1.4 billion for the year, up 64%. R&D spend was up 7% for the year to $1.8 billion.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters